Eisai
4523.T
#2079
Rank
S$12.04 B
Marketcap
S$42.68
Share price
6.09%
Change (1 day)
11.02%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2026 (TTM): S$0.48 Billion

According to Eisai's latest financial reports the company's current earnings are S$5.44 Billion. In 2025 the company made an earning of S$0.54 Billion a decrease over its 2024 earnings that were of S$0.68 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.48 B-10.96%
2025 S$0.54 B-20.48%
2024 S$0.68 B2.42%
2023 S$0.67 B-2404.04%
2022 -S$29.09 Million-103.6%
2021 S$0.80 B-39.81%
2020 S$1.34 B7.44%
2019 S$1.25 B17.22%
2018 S$1.06 B86.16%
2017 S$0.57 B-23.52%
2016 S$0.74 B26.97%
2015 S$0.59 B22.3%
2014 S$0.48 B-46.07%
2013 S$0.89 B-21.85%
2012 S$1.14 B-20.59%
2011 S$1.44 B-8.91%
2010 S$1.58 B19.21%
2009 S$1.32 B